Alkem Laboratories Ltd (BOM:539523)
₹ 5701.35 -20.05 (-0.35%) Market Cap: 682.30 Bil Enterprise Value: 653.78 Bil PE Ratio: 33.57 PB Ratio: 6.69 GF Score: 99/100

Q2 2020 Alkem Laboratories Ltd Earnings Call Transcript

Nov 11, 2019 / 11:30AM GMT
Release Date Price: ₹1964.3 (-3.46%)
Operator

Ladies and gentlemen, good day and welcome to the Alkem Laboratories Q2 FY '20 Earnings Conference Call hosted by Motilal Oswal Financial Services Limited. (Operator Instructions) Please note that this conference is being recorded.

I would now like to hand the conference over to Mr. Tushar Manudhane from Motilal Oswal Financial Services. Thank you, and over to you, sir.

Tushar Manudhane
Motilal Oswal Securities Limited, Research Division - Research Analyst

Thanks, Janis. Good evening, everyone. Thanks for joining this call. From Alkem Senior Management team, we have Mr. Sandeep Singh, Managing Director; Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President International Business; Mr. Yogesh Kaushal, Senior Vice President, Chronic Division; and Mr. Gagan Borana from Investor releases. Over to you, Gagan.

Gagan Borana
Alkem Laboratories Limited - General Manager of IR

Thank you, Tushar. Good evening, everybody, and thank you for taking out time and joining us for Alkem Laboratories Q2 FY '20

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot